NCT01963351View on ClinicalTrials.gov

Bevacizumab in Combination With Chemotherapy in Patients With Advanced or Recurrent Non-squamous NSCLC

CompletedOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions

Non-small Cell Lung CancerUnresectable Malignant Neoplasm

Trial Locations (1)

115 27

Oncology Unit Sotiria Hospital of Chest Diseases, Athens

All Listed Sponsors

lead

University of Athens

OTHER

NCT01963351 - Bevacizumab in Combination With Chemotherapy in Patients With Advanced or Recurrent Non-squamous NSCLC | Biotech Hunter | Biotech Hunter